XML 24 R14.htm IDEA: XBRL DOCUMENT v3.23.3

Accounts Payable and Accrued Liabilities

9 Months Ended

Sep. 30, 2023

Payables and Accruals [Abstract]

Accounts Payable and Accrued Liabilities

Accounts Payable and Accrued Liabilities

Accounts payable and accrued liabilities consisted of the following:

(in millions)			September 30, 2023						December 31, 2022
Sales rebates and reserves			$	184.0					$	131.9
Income taxes payable			72.7						9.0
Accrued employee related costs			68.6						72.8
Current branded prescription drug fee			44.5						27.5
Accrued development costs			39.5						39.1
Accounts payable and other accrued liabilities			93.8						67.3
Total accounts payable and accrued liabilities			$	503.0					$	347.6

X

- Definition

The entire disclosure for accounts payable and accrued liabilities at the end of the reporting period.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.19(a),20,24)
-Publisher FASB
-URI https://asc.fasb.org//1943274/2147480566/210-10-S99-1

+ Details

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesDisclosureTextBlock
Namespace Prefix:	us-gaap_
Data Type:	dtr-types:textBlockItemType
Balance Type:	na
Period Type:	duration

X

- References

No definition available.

+ Details

Name:	us-gaap_PayablesAndAccrualsAbstract
Namespace Prefix:	us-gaap_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration